India Glycols Posts Rs 15.25 Crores Profit Before Tax for Q2 on Rs 358.51 Crores Revenue After Demerger
Standalone financial results for quarter and half year ended Sept 30, 2026 reflect demerger impact with Spirits and Biofuel businesses now separate entities
India Glycols Limited announced its unaudited standalone financial results for the quarter and half year ended 30th September 2026, reporting a Rs 15.25 crores profit before tax for Q2 and total revenue of Rs 358.51 crores. The results reflect the impact of the April 2026 demerger of Spirits, Biofuel and Biopharma undertakings, now operated by separate entities.
India Glycols Limited
Financial Results
India Glycols Limited announced its unaudited standalone financial results for the quarter and half year ended 30th September 2026, reporting a profit before tax of Rs 15.25 crores for Q2 on total income of Rs 358.51 crores. The company’s results reflect the demerger effective April 1, 2026, which transferred Spirits, Biofuel and Biopharma undertakings to separate entities.
The Board of Directors approved the unaudited standalone results on 13th November 2026 with the statutory auditors carrying out a limited review.
Total revenue from operations for Q2 was Rs 358.18 crores with total income including other income at Rs 358.51 crores. Expenses totalled Rs 343.26 crores, leading to an earnings before interest, depreciation, and tax (EBIDTA) of Rs 39.34 crores.
Profit before tax for the quarter stood at Rs 15.25 crores while the profit after tax was Rs 11.24 crores.
The half year ended 30th September 2026 recorded a profit before tax of Rs 31.79 crores on total income of Rs 713.52 crores.
The results exclude financial performance of the Spirits, Biofuel and Biopharma businesses due to their demerger into separate companies effective April 1, 2026, as approved by the National Company Law Tribunal on 17th July 2026.
Highlights
- Quarterly revenue from operations was Rs 358.18 crores for Q2 FY2026-27.
- Profit before tax for Q2 was Rs 15.25 crores; profit after tax was Rs 11.24 crores.
- Half year ended 30th Sept 2026 profit before tax was Rs 31.79 crores.
- Demerger of Spirits, Biofuel, and Biopharma businesses effective 1st April 2026 separated these undertakings into IGL Spirits Ltd and Ennature Bio Pharma Ltd.
- Comparison figures for prior periods include the demerged businesses and are not directly comparable.
Key Data Snapshot
What happened
- India Glycols Limited announced its unaudited standalone financial results for quarter and half year ended 30th September 2026.
- The Board approved the results on 13th November 2026 with limited review by auditors.
- Reported profit before tax for Q2 was Rs 15.25 crores on revenue from operations of Rs 358.18 crores.
Key details
- Revenue from operations was Rs 358.18 crores for Q2 and Rs 712.82 crores for the half year.
- Profit after tax for Q2 was Rs 11.24 crores and for the half year was Rs 23.59 crores.
- Demerger of Spirits, Biofuel, and Biopharma Undertakings effective 1st April 2026 transferred these operations to IGL Spirits Ltd and Ennature Bio Pharma Ltd.
- Comparison with prior periods is limited as earlier results included the demerged undertakings.
- Total expenses for the quarter were Rs 343.26 crores.
Regulatory and governance context
- The Scheme of Arrangement was approved by the National Company Law Tribunal, Allahabad Bench on 17th July 2026.
- The demerger became effective on 1st September 2026 with appointed date of 1st April 2026.
- All carrying values of assets, liabilities and identified reserves of the demerged undertakings have been transferred to the respective resulting companies.
- The difference in the carrying values was adjusted in other equity of India Glycols Limited.
Background and context
- The company’s businesses are identified as a single reportable segment: Bio-based Specialities and Performance Chemicals after the demerger.
- The Spirits and Biofuel and Biopharma businesses were significant in prior periods but have now demerged to separate companies.
- Financial results for current periods exclude the demerged undertakings, while comparative figures include them, making direct comparisons not meaningful.
Highlights
- Quarterly revenue from operations was Rs 358.18 crores for Q2 FY2026-27.
- Profit before tax for Q2 was Rs 15.25 crores; profit after tax was Rs 11.24 crores.
- Half year ended 30th Sept 2026 profit before tax was Rs 31.79 crores.
- Demerger of Spirits, Biofuel, and Biopharma businesses effective 1st April 2026 separated these undertakings into IGL Spirits Ltd and Ennature Bio Pharma Ltd.
- Comparison figures for prior periods include the demerged businesses and are not directly comparable.
Disclosures
- Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Source Information
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Kaynes Technology India Limited Reports Q2 FY2027 Un-audited Results and Enters Joint Venture to Produce TFT Modules
Kaynes Technology India Limited released its un-audited financial results for the quarter and half year ended September 30, 2026, and approved a joint venture with Toyokawa Techno Private Limited to produce Thin-Film Transistor Display Modules in India, while proposing voluntary strike-off of a subsidiary.
Read Full StoryITI Limited Reports ₹49,528 Lakh Revenue and ₹6,368 Lakh Consolidated Loss Before Tax for Half Year Ending September 2026
ITI Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026, revealing total consolidated revenue of ₹49,528 lakh for the quarter and a consolidated loss before tax of ₹6,368 lakh for the half-year period.
Read Full StoryZetwerk Manufacturing Businesses Limited Reports Q2 FY2027 Loss with Rs. 886.06 Million Receivables Dispute, Appoints New Company Secretary
Zetwerk Manufacturing Businesses Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, reporting a loss before tax of Rs. 1,193.17 million for the quarter. The company highlighted ongoing litigation over receivables totaling Rs. 886.06 million, alongside key administrative updates.
Read Full Story